No menu items!
spot_img

MINILUXE COMPLETES SHARES FOR DEBT SETTLEMENT

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Boston, MA, Sept. 26,...

COTY SHAREHOLDER ALERT: Coty Inc. Investors may have been Affected by Fraud — Contact BFA Law about its Investigation

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coty...

Top Stories

TryHard Holdings Limited Celebrates Nasdaq Listing with Closing Bell Ceremony, Marking...

TryHard Holdings Limited – Closing Bell Ceremony on Nasdaq Stock Market in New YorkPhoto source: Nasdaq, Inc. OSAKA, Japan, Sept. 26, 2025 (GLOBE NEWSWIRE) --...

COTY SHAREHOLDER ALERT: Coty Inc. Investors may have been Affected by...

NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coty Inc. (NYSE: COTY) for potential violations of the federal securities laws. If you invested in Coty, you are encouraged to obtain additional information by...

Most Popular

COTY SHAREHOLDER ALERT: Coty Inc. Investors may have been Affected by...

TryHard Holdings Limited Celebrates Nasdaq Listing with Closing Bell Ceremony, Marking...

Love Buying British Introduces Comprehensive Directory Connecting Consumers with Authentic British-Made...

Beauty and Personal Care Products Market Report by Type, Product, Pricing,...

MoonLake Immunotherapeutics reports on week 16 results of the VELA Phase...

JZXN Appoints Dr. Doug Buerger as Chief Operating Officer to Advance...

HANGZHOU, China, Sept. 23, 2025 /PRNewswire/ -- JZXN Holdings, Inc. (NASDAQ: JZXN; the "Company") announced the appointment of Dr. Doug Buerger as Chief Operating Officer (COO), effective immediately. Dr. Buerger brings more than 30 years of leadership experience in blockchain, artificial intelligence, and digital currency ecosystems. He...

Numab Therapeutics Achieves Milestone in Collaboration with Boehringer Ingelheim

Numab to receive first milestone payment Boehringer Ingelheim has advanced its novel tumor antigen targeting T cell engager resulting from a collaboration with Numab into preclinical development ...
spot_img

Category

Danam Health, Inc. Announces Acquisition of Wood Sage, LLC

YourUpdateTV speaks with Meaghan B. Murphy